Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Welcome to the Cipla Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent ...

So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...

The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly ...

>> Long build up is seen in CIPLA Futures, where we have seen 4 per cent rise in the open interest on the day when Cipla ...

Mahindra Lifespace Developers Ltd., Bank of India, Rail Vikas Nigam Ltd., Container Corp. and Cipla Ltd. are some of the ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.

Cipla share price will remain in focus after the United States Food and Drug Administration (USFDA) has classified the ...

HYDERABAD/BENGALURU, Jan 28 (Reuters) - Cipla (CIPL.NS), opens new tab, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong ...

After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...